{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 12,
        "end": 42
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 45,
        "end": 49
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 136,
        "end": 148
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 152,
        "end": 168
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 216,
        "end": 231
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 234,
        "end": 236
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22741564_4",
  "text": "Currently , thiopurine S-methyltransferase ( TPMT ) deficiency is the only pharmacogenetic factor that is prospectively assessed before azathioprine or 6-mercaptopurine immunomodulation is commenced in patients with Crohn's disease ( CD ) ."
}
